KIT-negative gastrointestinal stromal tumors with a long term follow-up: A new subgroup does exist

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

204

HTML

1192

Figures (1-4)

145

Tables (1-4)

106

Sum=1647

Feb 21, 2007 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 21, 2007; 13(7): 1098-1102
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1098

Figure 1 Histological section of GIST showing positive immunostaining for KIT (CD117 antigen) × 400.

Figure 2 Cumulative survival for patients with GISTs based on tumor location.

Figure 3 Cumulative survival for patients with GISTs based on mitotic counts.

Figure 4 Cumulative survival for patients with GISTs based on metastasis status.

Citation: Kontogianni-Katsarou K, Lariou C, Tsompanaki E, Vourlakou C, Kairi-Vassilatou E, Mastoris C, Pantazi G, Kondi-Pafiti A. KIT-negative gastrointestinal stromal tumors with a long term follow-up: A new subgroup does exist. World J Gastroenterol 2007; 13(7): 1098-1102
URL: https://www.wjgnet.com/1007-9327/full/v13/i7/1098.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i7.1098